UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KS
1626
DELISTED
KapStone Paper and Pack Corp.
KS
| $1M | ﹤0.01% |
43,302
+3,504
| +9% | +$96.7K |
|
1627
Boyd Gaming
BYD
$6.11B
| $1M | ﹤0.01% |
66,898
+6,300
| +10% | +$89K |
|
|
PMT
1628
PennyMac Mortgage Investment
PMT
$814M
| $991K | ﹤0.01% |
56,863
+6,200
| +12% | +$121K |
|
|
STL
1629
DELISTED
Sterling Bancorp
STL
| $991K | ﹤0.01% |
67,422
+6,000
| +10% | +$81.6K |
|
|
DGI
1630
DELISTED
DigitalGlobe Inc.
DGI
| $989K | ﹤0.01% |
35,595
+3,100
| +10% | +$97.8K |
|
|
MGLN
1631
DELISTED
Magellan Health Services, Inc.
MGLN
| $988K | ﹤0.01% |
14,099
+1,300
| +10% | +$88.4K |
|
|
NUVA
1632
DELISTED
NuVasive, Inc.
NUVA
| $985K | ﹤0.01% |
20,799
+2,600
| +14% | +$122K |
|
1633
Ultragenyx Pharmaceutical
RARE
$2.54B
| $983K | ﹤0.01% |
9,600
+1,500
| +19% | +$116K |
|
1634
Central Garden & Pet Co Class A
CENTA
$2.54B
| $982K | ﹤0.01% |
107,556
+77,556
| +259% | +$642K |
|
|
MASI
1635
DELISTED
Masimo
MASI
| $980K | ﹤0.01% |
25,298
+3,000
| +13% | +$107K |
|
1636
Capitol Federal Financial
CFFN
$1.11B
| $979K | ﹤0.01% |
81,268
+8,772
| +12% | +$107K |
|
|
SFLY
1637
DELISTED
Shutterfly, Inc.
SFLY
| $975K | ﹤0.01% |
20,399
-141,400
| -87% | -$6.56M |
|
1638
Morningstar
MORN
$7.37B
| $970K | ﹤0.01% |
12,192
+800
| +7% | +$61.3K |
|
1639
Artisan Partners
APAM
$3.06B
| $968K | ﹤0.01% |
20,828
+1,700
| +9% | +$77.8K |
|
1640
Nektar Therapeutics
NKTR
$2.48B
| $965K | ﹤0.01% |
5,140
+660
| +15% | +$114K |
|
1641
Haemonetics
HAE
$3.86B
| $964K | ﹤0.01% |
23,298
-164,752
| -88% | -$6.95M |
|
|
LNCE
1642
DELISTED
Snyders-Lance, Inc.
LNCE
| $963K | ﹤0.01% |
29,854
+2,700
| +10% | +$83.3K |
|
|
AXON
1643
Axon Enterprise
AXON
$42.1B
| $959K | ﹤0.01% |
28,798
+3,200
| +13% | +$100K |
|
1644
Carpenter Technology
CRS
$27.7B
| $959K | ﹤0.01% |
24,798
-6,682
| -21% | -$279K |
|
1645
MasTec
MTZ
$20.8B
| $958K | ﹤0.01% |
48,236
+4,900
| +11% | +$91.6K |
|
|
ESND
1646
DELISTED
Essendant Inc.
ESND
| $957K | ﹤0.01% |
24,399
+1,800
| +8% | +$72.8K |
|
|
EFOR
1647
Everforth Inc
EFOR
$1.29B
| $954K | ﹤0.01% |
24,298
+2,700
| +13% | +$103K |
|
|
TERP
1648
DELISTED
TerraForm Power, Inc
TERP
| $953K | ﹤0.01% |
25,100
+6,300
| +34% | +$249K |
|
|
SLCA
1649
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $946K | ﹤0.01% |
32,217
+3,868
| +14% | +$131K |
|
1650
Chemed
CHE
$7.18B
| $944K | ﹤0.01% |
7,200
+600
| +9% | +$74.2K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.